Ultimately, the identification of OTUD4 adds greater resolution to our knowledge surrounding the cell’s ability to regulate the TGFβ pathway and defines OTUD4 as a biomarker for TGFβ activity, with its expression acting in proxy to reveal the intrinsic activity of this cancer-relevant pathway. The gene discussed is TGFB1; the disease is cancer.